Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation - Pan, C W; Pan, Z Z; Hu, J J (Eur J Pharmacol, 2016)
et al.